syrosingopine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
derivatives of Rauwolfia alkaloids 2550 84-36-6

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • syrosingopine
  • methyl carbethoxysyringoyl reserpate
  • singoserp
  • syringopine
  • syrosingopin
  • Molecular weight: 666.72
  • Formula: C35H42N2O11
  • CLOGP: 3.60
  • LIPINSKI: 2
  • HAC: 13
  • HDO: 1
  • TPSA: 144.08
  • ALOGS: -4.83
  • ROTB: 13

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 3.688 High 0.87
caco2-efflux Caco-2 efflux ratio (BA/AB) 1.309 High 0.87
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 25.235 10^-6 cm/s High 0.87
dh-clint Dog hepatocyte intrinsic clearance 65.163 uL/min/10^6 cells High 0.87
dppb Dog plasma protein binding (% unbound) 2.130 % High 0.87
fcs-ppb Fetal calf serum protein binding (% unbound) 5.070 % High 0.87
herg hERG pIC50 5.244 pIC50 High 0.87
hh-clint Human hepatocyte intrinsic clearance 140.929 uL/min/10^6 cells High 0.87
hlm-clint Human liver microsomal intrinsic clearance 198.609 uL/min/mg protein High 0.87
hppb Human plasma protein binding (% unbound) 1.870 % High 0.87
kinase-safety-class ACVR2B,AKT2,AKT3,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK5,CDK9,DYRK1B,EIF2AK3,EPHB4,ERBB2,GRK2,ITK,JAK2,JAK3,MAP2K6,MAP3K7,MAPK10,MAPK7,MAPKAPK2,MET,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CA,PIK3CB,PIK3CD,PIM2,PRKDC,STK33,TEK,TGFBR1,ZAP70 39
kinase-selectivity-class AXL,GRK2 2
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 1.585 High 0.87
mh-clint Mouse hepatocyte intrinsic clearance 207.491 High 0.87
mppb Mouse plasma protein binding (% unbound) 2.450 High 0.87
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 5.272 High 0.87
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pppb Pig plasma protein binding (% unbound) 6.430 % High 0.87
rh-clint Rat hepatocyte intrinsic clearance 291.743 uL/min/10^6 cells High 0.87
rh-fuinc Rat hepatocyte fraction unbound in incubation 16.760 % High 0.87
rppb Rat plasma protein binding (% unbound) 1.490 % High 0.87
solubility-dd Solubility at pH 7.4 in DMSO 2.904 uM High 0.87

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC C02LA09 CARDIOVASCULAR SYSTEM
ANTIHYPERTENSIVES
ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION
Rauwolfia alkaloids and diuretics in combination

Related Drugs by ATC class:

C02LA Rauwolfia alkaloids and diuretics in combination 5 drugs
bietaserpinedeserpidinemethoserpidinerescinnaminereserpine

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 11.2 acidic
pKa2 6.78 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])		Mechanism
action		Bioact sourceMoA source
Monocarboxylate transporter 4 Transporter IC50 9 CHEMBL

External reference:

IDSource
D01659 KEGG_DRUG
C0039148 UMLSCUI
CHEBI:32175 CHEBI
CHEMBL1399124 ChEMBL_ID
C084824 MESH_SUPPLEMENTAL_RECORD_UI
849 INN_ID
PPG46JF0EG UNII
6769 PUBCHEM_CID
000649 NDDF
12208001 SNOMEDCT_US

Pharmaceutical products:

None